Edmond de Rothschild Holding’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,000
| Closed | -$34K | – | 571 |
|
|
2025
Q1 | $34K | Hold |
1,000
| – | – | ﹤0.01% | 484 |
|
|
2024
Q4 | $39.4K | Hold |
1,000
| – | – | ﹤0.01% | 515 |
|
|
2024
Q3 | $47K | Hold |
1,000
| – | – | ﹤0.01% | 527 |
|
|
2024
Q2 | $54K | Buy |
+1,000
| New | +$54K | ﹤0.01% | 554 |
|
|
2022
Q4 | – | Sell |
-3,341
| Closed | -$218K | – | 790 |
|
|
2022
Q3 | $218K | Hold |
3,341
| – | – | 0.01% | 449 |
|
|
2022
Q2 | $203K | Buy |
+3,341
| New | +$203K | ﹤0.01% | 481 |
|
|
2022
Q1 | – | Sell |
-200
| Closed | -$15K | – | 815 |
|
|
2021
Q4 | $15K | Sell |
200
-15,676
| -99% | -$1.18M | ﹤0.01% | 779 |
|
|
2021
Q3 | $1.78M | Sell |
15,876
-9,761
| -38% | -$1.09M | 0.04% | 295 |
|
|
2021
Q2 | $4.15M | Buy |
25,637
+19,431
| +313% | +$3.15M | 0.1% | 183 |
|
|
2021
Q1 | $756K | Buy |
6,206
+4,914
| +380% | +$599K | 0.02% | 351 |
|
|
2020
Q4 | $198K | Buy |
+1,292
| New | +$198K | 0.01% | 440 |
|